1. Moon JS. Secular trends of body sizes in Korean children and adolescents: from 1965 to 2010. Korean J Pediatr. 2011; 54(11):436–442.
Article
2. Reilly JJ, Methven E, McDowell ZC, Hacking B, Alexander D, Stewart L, Kelnar CJ. Health consequences of obesity. Arch Dis Child. 2003; 88(9):748–752.
Article
3. Bouchard C. Current understanding of the etiology of obesity: genetic and nongenetic factors. Am J Clin Nutr. 1991; 53:6 Suppl. 1561S–1565S.
Article
4. Comuzzie AG, Allison DB. The search for human obesity genes. Science. 1998; 280(5368):1374–1377.
Article
5. Alfredo Martínez J, Enríquez L, Moreno-Aliaga MJ, Martí A. Genetics of obesity. Public Health Nutr. 2007; 10(10A):1138–1144.
6. Hamm HE. The many faces of G protein signaling. J Biol Chem. 1998; 273(2):669–672.
Article
7. Oldham WM, Hamm HE. Heterotrimeric G protein activation by G-protein-coupled receptors. Nat Rev Mol Cell Biol. 2008; 9(1):60–71.
Article
8. Tesmer JJ. The quest to understand heterotrimeric G protein signaling. Nat Struct Mol Biol. 2010; 17(6):650–652.
Article
9. Thathiah A, De Strooper B. The role of G protein-coupled receptors in the pathology of Alzheimer's disease. Nat Rev Neurosci. 2011; 12(2):73–87.
Article
10. Brinks HL, Eckhart AD. Regulation of GPCR signaling in hypertension. Biochim Biophys Acta. 2010; 1802(12):1268–1275.
Article
11. Lappano R, Maggiolini M. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov. 2011; 10(1):47–60.
Article
12. Vassart G, Costagliola S. G protein-coupled receptors: mutations and endocrine diseases. Nat Rev Endocrinol. 2011; 7(6):362–372.
Article
13. Rosskopf D, Busch S, Manthey I, Siffert W. G protein beta 3 gene: structure, promoter, and additional polymorphisms. Hypertension. 2000; 36(1):33–41.
14. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet. 1998; 18(1):45–48.
15. Siffert W, Naber C, Walla M, Ritz E. G protein β3 subunit 825T allele and its potential association with obesity in hypertensive individuals. J Hypertens. 1999; 17(8):1095–1098.
Article
16. Klenke S, Kussmann M, Siffert W. The GNB3 C825T polymorphism as a pharmacogenetic marker in the treatment of hypertension, obesity, and depression. Pharmacogenet Genomics. 2011; 21(9):594–606.
Article
17. Hegele RA, Harris SB, Hanley AJ, Cao H, Zinman B. G protein beta3 subunit gene variant and blood pressure variation in Canadian Oji-Cree. Hypertension. 1998; 32(4):688–692.
18. Siffert W, Rosskopf D, Erbel R. Genetic polymorphism of the Gprotein beta3 subunit, obesity and essential hypertension. Herz. 2000; 25(1):26–33.
19. Poch E, Giner V, González-Núñez D, Coll E, Oriola J, de la Sierra A. Association of the G protein beta3 subunit T allele with insulin resistance in essential hypertension. Clin Exp Hypertens. 2002; 24(5):345–353.
20. Brand E, Wang JG, Herrmann SM, Staessen JA. An epidemiological study of blood pressure and metabolic phenotypes in relation to the Gbeta3 C825T polymorphism. J Hypertens. 2003; 21(4):729–737.
21. Siffert W, Forster P, Jöckel KH, Mvere DA, Brinkmann B, Naber C, Crookes R, Du P, Epplen JT, Fridey J, Freedman BI, Müller N, Stolke D, Sharma AM, Al Moutaery K, Grosse-Wilde H, Buerbaum B, Ehrlich T, Ahmad HR, Horsthemke B, Du Toit ED, Tiilikainen A, Ge J, Wang Y, Rosskopf D, Rosskopf D. Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol. 1999; 10(9):1921–1930.
22. Li B, Ge D, Wang Y, Zhao W, Zhou X, Gu D, Chen R. G protein β3 subunit gene variants and essential hypertension in the northern Chinese Han population. Ann Hum Genet. 2005; 69(Pt 4):468–473.
Article
23. Bae Y, Park C, Han J, Hong YJ, Song HH, Shin ES, Lee JE, Han BG, Jang Y, Shin DJ, Yoon SK. Interaction between GNB3 C825T and ACE I/D polymorphisms in essential hypertension in Koreans. J Hum Hypertens. 2007; 21(2):159–166.
Article
24. Ko KD, Kim KK, Suh HS, Hwang IC. Associations between the GNB3 C825T polymorphism and obesity-related metabolic risk factors in Korean obese women. J Endocrinol Invest. 2014; 37(11):1117–1120.
Article
25. Hwang IC, Kim KK, Ahn HY, Suh HS, Oh SW. Effect of the Gprotein beta3 subunit 825T allele on the change of body adiposity in obese female. Diabetes Obes Metab. 2013; 15(3):284–286.
26. Babu A, Fogelfeld L. Metabolic syndrome and prediabetes. Dis Mon. 2006; 52(2-3):55–144.
Article
27. Vekic J, Topic A, Zeljkovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V. LDL and HDL subclasses and their relationship with Framingham risk score in middle-aged Serbian population. Clin Biochem. 2007; 40(5-6):310–316.
Article
28. Camont L, Chapman MJ, Kontush A. Biological activities of HDL subpopulations and their relevance to cardiovascular disease. Trends Mol Med. 2011; 17(10):594–603.
Article
29. Lamarche B, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després JP. Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol. 1997; 17(6):1098–1105.
30. Lee M, Jang Y, Kim K, Cho H, Jee SH, Park Y, Kim MK. Relationship between HDL3 subclasses and waist circumferences on the prevalence of metabolic syndrome: KMSRI-Seoul Study. Atherosclerosis. 2010; 213(1):288–293.
Article
31. Moon JS, Lee SY, Nam CM, Choi JM, Choe BK, Seo JW, Oh K, Jang MJ, Hwang SS, Yoo MH, Kim YT, Lee CG. 2007 Korean National Growth Charts: review of developmental process and an outlook. Korean J Pediatr. 2008; 51(1):1–25.
Article
32. Seo J, Cho Y, Kang J, Hur Y, Park H, Kim K, Kwon S. New diagnostic criteria for obesity and overweight in Korean children and adolescents using 2007 Korean National Growth Charts. Obes Res Clin Pract. 2013; 7(3):e182–e189.
Article
33. Lee M, Kim MK, Kim SM, Park H, Park CG, Park HK. Genderbased differences on the association between salt-sensitive genes and obesity in Korean children aged between 8 and 9 years. PLoS One. 2015; 10(3):e0120111.
Article
34. Pérusse M, Pascot A, Després JP, Couillard C, Lamarche B. A new method for HDL particle sizing by polyacrylamide gradient gel electrophoresis using whole plasma. J Lipid Res. 2001; 42(8):1331–1334.
Article
35. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997; 65:4 Suppl. 1220S–1228S.
Article
36. Frey UH, Moebus S, Möhlenkamp S, Kälsch H, Bauer M, Lehmann N, Nöthen M, Mühleisen TW, Stang A, Erbel R, Jöckel KH, Peters J, Siffert W. GNB3 gene 825 TT variant predicts hard coronary events in the population-based Heinz Nixdorf Recall study. Atherosclerosis. 2014; 237(2):437–442.
Article
37. Garcés C, Gutierrez-Guisado J, Benavente M, Cano B, Viturro E, Ortega H, de Oya M. Obesity in Spanish schoolchildren: relationship with lipid profile and insulin resistance. Obes Res. 2005; 13(6):959–963.
Article
38. Numata M. High density lipoprotein particle size in children: relation to atherogenic dyslipidemia. Clin Pediatr Endocrinol. 2004; 13(1):1–9.
Article
39. Hegele RA, Anderson C, Young TK, Connelly PW. G-protein beta3 subunit gene splice variant and body fat distribution in Nunavut Inuit. Genome Res. 1999; 9(10):972–977.
40. Benjafield AV, Lin RC, Dalziel B, Gosby AK, Caterson ID, Morris BJ. G-protein beta3 subunit gene splice variant in obesity and overweight. Int J Obes Relat Metab Disord. 2001; 25(6):777–780.
41. Rankinen T, Rice T, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C. G protein beta 3 polymorphism and hemodynamic and body composition phenotypes in the HERITAGE Family Study. Physiol Genomics. 2002; 8(2):151–157.